The macrophage stimulating protein/Ron pathway as a potential therapeutic target to impede multiple mechanisms involved in breast cancer progression
- PMID: 20545605
- DOI: 10.2174/138945010792006825
The macrophage stimulating protein/Ron pathway as a potential therapeutic target to impede multiple mechanisms involved in breast cancer progression
Abstract
Macrophage Stimulating Protein (MSP) is the only known ligand for the receptor tyrosine kinase Ron. The MSP/Ron pathway is involved in several important biological processes, including macrophage activity, wound healing, and epithelial cell behavior. A role for MSP/Ron in breast cancer has recently been elucidated, wherein this pathway regulates tumor growth, angiogenesis, and metastasis. Here, we review the recent literature surrounding MSP/Ron function in tumor cells, inflammatory cells, and osteoclasts - cell types that often coexist in breast tumor microenvironments. We discuss the potential implications of MSP/Ron activity occurring concurrently in these cell types on tumor progression and metastasis. Lastly, we outline the potential for targeting MSP/Ron as a novel therapy for breast cancer, and for other cancer types.
Similar articles
-
The MSP-RON axis stimulates cancer cell growth in models of triple negative breast cancer.Mol Oncol. 2020 Aug;14(8):1868-1880. doi: 10.1002/1878-0261.12734. Epub 2020 Jun 17. Mol Oncol. 2020. PMID: 32484599 Free PMC article.
-
Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase.Carcinogenesis. 2003 Aug;24(8):1291-300. doi: 10.1093/carcin/bgg089. Epub 2003 May 22. Carcinogenesis. 2003. PMID: 12807733 Review.
-
Functional consequences of the macrophage stimulating protein 689C inflammatory bowel disease risk allele.PLoS One. 2013 Dec 23;8(12):e83958. doi: 10.1371/journal.pone.0083958. eCollection 2013. PLoS One. 2013. PMID: 24409221 Free PMC article.
-
Inhibition of MSP-RON signaling pathway in cancer cells by a novel soluble form of RON comprising the entire sema sequence.Int J Oncol. 2010 Jun;36(6):1551-61. doi: 10.3892/ijo_00000642. Int J Oncol. 2010. PMID: 20428780
-
Oncogenic signaling pathways activated by RON receptor tyrosine kinase.Curr Cancer Drug Targets. 2003 Feb;3(1):31-40. doi: 10.2174/1568009033333745. Curr Cancer Drug Targets. 2003. PMID: 12570659 Review.
Cited by
-
Blocking Short-Form Ron Eliminates Breast Cancer Metastases through Accumulation of Stem-Like CD4+ T Cells That Subvert Immunosuppression.Cancer Discov. 2021 Dec 1;11(12):3178-3197. doi: 10.1158/2159-8290.CD-20-1172. Cancer Discov. 2021. PMID: 34330779 Free PMC article.
-
Microparticles shed from multidrug resistant breast cancer cells provide a parallel survival pathway through immune evasion.BMC Cancer. 2017 Feb 6;17(1):104. doi: 10.1186/s12885-017-3102-2. BMC Cancer. 2017. PMID: 28166767 Free PMC article.
-
Distinct involvement of the Gab1 and Grb2 adaptor proteins in signal transduction by the related receptor tyrosine kinases RON and MET.J Biol Chem. 2011 Sep 16;286(37):32762-74. doi: 10.1074/jbc.M111.239384. Epub 2011 Jul 22. J Biol Chem. 2011. PMID: 21784853 Free PMC article.
-
The RON receptor tyrosine kinase promotes metastasis by triggering MBD4-dependent DNA methylation reprogramming.Cell Rep. 2014 Jan 16;6(1):141-54. doi: 10.1016/j.celrep.2013.12.010. Epub 2014 Jan 2. Cell Rep. 2014. PMID: 24388747 Free PMC article.
-
Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinase.J Immunol. 2011 Sep 1;187(5):2181-92. doi: 10.4049/jimmunol.1003460. Epub 2011 Aug 1. J Immunol. 2011. PMID: 21810604 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials